Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S2 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
  1. Home
  2. Publications
  3. Figure S2 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers

Figure S2 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers

Authors:
  • KKKyung-Don Kang
    Kyung-Don Kang
  • JBJoshua D. Bernstock
    Joshua D. Bernstock
  • STStacie K. Totsch
    Stacie K. Totsch
  • SGSam E. Gary
    Sam E. Gary
  • ARAbbey Rocco
    Abbey Rocco
  • LNLi Nan
    Li Nan
  • RLRong Li
    Rong Li
  • TETina Etminan
    Tina Etminan
  • XHXiaosi Han
    Xiaosi Han
  • EBElizabeth A. Beierle
    Elizabeth A. Beierle
  • TETanja Eisemann
    Tanja Eisemann
  • RWRobert J. Wechsler-Reya
    Robert J. Wechsler-Reya

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30706068
Abstract
Toxicity from IVT oHSV in the left lateral ventricle and third and fourth ventricles at different time points.
Keywords
  • BIOLOGICAL AGENTS & THERAPIES
  • GENE THERAPY
  • CNS CANCERS
  • IMMUNOTHERAPY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.